We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

12 hedge funds and large institutions have $5.25M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 529 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

98% less funds holding

Funds holding: 546 → 12 (-534)

98% less capital invested

Capital invested by funds: $338M → $5.25M (-$333M)

100% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 529

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
12
Holders Change
-534
Holders Change %
-97.8%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
529
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
Jet Capital Investors
New York
+$2.15M
2
TNB
Thomasville National Bank
Georgia
+$146K

Top Sellers

1
PCM
Pentwater Capital Management
Florida
-$47.7M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$20.6M
3
ACM
Abrams Capital Management
Massachusetts
-$17.1M
4
FCM
Farallon Capital Management
California
-$14.8M
5
BFS
Bard Financial Services
Connecticut
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
351
Parallel Advisors
California
– -$3K -4,867 Closed
SC
352
SRB Corp
Massachusetts
– -$4K -4,770 Closed
DSC
353
Duncker Streett & Co
Missouri
– -$3K -4,715 Closed
CWM
354
Connecticut Wealth Management
Connecticut
– -$248K -4,508 Closed
QP
355
Quilter Plc
United Kingdom
– -$2K -4,379 Closed
Bank Julius Baer & Co
356
Bank Julius Baer & Co
Switzerland
– -$3K -4,348 Closed
SPIA
357
Steward Partners Investment Advisory
New York
– -$3K -4,243 Closed
JCM
358
Jacobi Capital Management
Pennsylvania
– -$3K -4,215 Closed
RWA
359
Ropes Wealth Advisors
Massachusetts
– -$3K -4,182 Closed
SFS
360
Sowell Financial Services
Arkansas
– -$3K -4,009 Closed
HNB
361
Huntington National Bank
Ohio
– -$2K -3,980 Closed
HPC
362
HM Payson & Co
Maine
– -$3K -3,971 Closed
GIP
363
Granite Investment Partners
California
– -$3K -3,958 Closed
MIM
364
Merrion Investment Management
New Jersey
– -$3K -3,885 Closed
BFEC
365
Benjamin F. Edwards & Company
Missouri
– -$2K -3,618 Closed
GTAM
366
Global Trust Asset Management
Florida
– -$2K -3,422 Closed
APW
367
Acima Private Wealth
Virginia
– -$2K -3,342 Closed
CB
368
Community Bank
New York
– -$2K -3,200 Closed
BDWM
369
Brewin Dolphin Wealth Management
Ireland
– -$2.17K -3,150 Closed
IBOK
370
Independence Bank of Kentucky
Kentucky
– -$2K -3,036 Closed
OIA
371
Optimum Investment Advisors
Illinois
– -$2K -3,000 Closed
KTC
372
Kistler-Tiffany Companies
Pennsylvania
– -$2K -2,864 Closed
APA
373
American Portfolios Advisors
New York
– -$1.91K -2,764 Closed
FBT
374
First Bank & Trust
South Dakota
– -$2K -2,719 Closed
SNT
375
Security National Trust
West Virginia
– -$2K -2,699 Closed
13 14
15
16 17

BMY.RT Hedge Fund Activity: Q1 2021 in Review

12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q1 2021, worth a combined $5.25M — down 98% from $338M a quarter earlier.

Sellers outnumbered buyers: 529 funds closed out of BMY.RT and 2 opened new positions — a net loss of 527 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Jet Capital Investors, adding an estimated $2.15M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $47.7M sold.

  • 12 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q1 2021, down from 546 in Q4 2020.
  • Funds reported $5.25M of Bristol-Myers Squibb Company Contingent Value Rights stock for Q1 2021, down 98% quarter-over-quarter.
  • 2 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q1 2021 and 529 closed out, a net change of -527 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q1 2021 was Jet Capital Investors, an estimated $2.15M added.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q1 2021 was Pentwater Capital Management, an estimated $47.7M sold.

Based on aggregated 13F filings for Q1 2021.